Ghana, Rwanda and Senegal have partnered with German biotechnology company, BioNTech SE, to fill, finish, and package BioNTech mRNA vaccines in Africa.
Germany, President Nana Addo Dankwa Akufo-Addo and President Macky Sall of Senegal, as well as President Paul Kagame of Rwanda, witnessed the official presentation of a BioNTech modular production facility, for the production of mRNA vaccines in Africa.
The BioNTainer is equipped to manufacture a range of mRNA-based approved vaccines specifically to the needs of African member states.